Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001, 25: 603-625. 10.1016/S0145-2126(01)00038-8.
Article
CAS
PubMed
Google Scholar
Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD: Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007, 37: 435-453. 10.1111/j.1365-2362.2007.01807.x.
Article
CAS
PubMed
Google Scholar
Homann J, Kolck UW, Ehnes A, Frieling T, Raithel M, Molderings GJ: Systemic mastocytosis - definition of an internal disease. Med Klin (Munich). 2010, 105: 544-553. 10.1007/s00063-010-1093-8.
Article
Google Scholar
Akin C, Valent P, Metcalfe DD: Mast cell activation syndrome: Proposed diagnostic criteria. J Allergy Clin Immunol. 2010, 126: 1099-1104. 10.1016/j.jaci.2010.08.035.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hamilton MJ, Castells M, Greenberger NJ: Mast cell activation syndrome - a newly recognized cause of recurrent acute abdominal pain. Gastroenterology. 2010, 138 (Suppl 1): S89-
Google Scholar
Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L: Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol. 2010, 125: 1269-1278. 10.1016/j.jaci.2010.02.019.
Article
CAS
PubMed
Google Scholar
Molderings GJ, Kolck UW, Scheurlen C, Brüss M, Homann J, von Kügelgen I: Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder. Scand J Gastroenterol. 2007, 42: 1045-1053. 10.1080/00365520701245744.
Article
CAS
PubMed
Google Scholar
Molderings GJ, Meis K, Kolck UW, Homann J, Frieling T: Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects. Immunogenetics. 2010, 62: 721-727. 10.1007/s00251-010-0474-8.
Article
CAS
PubMed
Google Scholar
Horan RF, Austen KF: Systemic mastocytosis: retrospective review of a decade's clinical experience at the brigham and the women's hospital. Invest Dermatol. 1991, 96: 5S-14S. 10.1111/1523-1747.ep12468899.
Article
Google Scholar
Castells M: Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am. 2006, 26: 465-485. 10.1016/j.iac.2006.05.005.
Article
PubMed
Google Scholar
Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmérini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A: Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS ONE. 2008, 3: e2266-10.1371/journal.pone.0002266.
Article
PubMed Central
PubMed
Google Scholar
Alfter K, von Kügelgen I, Haenisch B, Frieling T, Hülsdonk A, Haars U, Rolfs A, Noe G, Kolck UW, Homann J, Molderings GJ: New aspects of liver abnormalities as part of the systemic mast cell activation syndrome. Liver Int. 2009, 29: 181-186. 10.1111/j.1478-3231.2008.01839.x.
Article
CAS
PubMed
Google Scholar
Escribano L, Alvarez-Twose I, Sánchez-Muñoz L, Garcia-Montero A, Núñez R, Almeida J, Jara-Acevedo M, Teodósio C, García-Cosío M, Bellas C, Orfao A: Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol. 2009, 124: 514-521. 10.1016/j.jaci.2009.05.003.
Article
PubMed
Google Scholar
Lim KH, Pardanani A, Butterfield JH, Li CY, Tefferi A: Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. Am J Hematol. 2009, 84: 790-794. 10.1002/ajh.21561.
Article
CAS
PubMed
Google Scholar
Lundequist A, Pejler G: Biological implications of preformed mast cell mediators. Cell Mol Life Sci. 2011, 68: 965-675. 10.1007/s00018-010-0587-0.
Article
CAS
PubMed
Google Scholar
Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, Metcalfe DD: Demonstration of an aberrant mast cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood. 2007, 110: 2331-2333. 10.1182/blood-2006-06-028100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gonzalez de Olano D, de la Hoz Caballer B, Nunez Lopez R, Sanchez Munoz L, Cuevas Agustin M, Dieguez MC, Alvarez Twose I, Castells MC, Escribano Mora L: Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy. 2007, 37: 1547-1555.
CAS
PubMed
Google Scholar
Brockow K, Jofer C, Behrendt H, Ring J: Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008, 63: 226-232. 10.1111/j.1398-9995.2007.01569.x.
Article
CAS
PubMed
Google Scholar
Sant GR, Kempuraj D, Marchand JE, Theoharides TC: The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007, 69 (4 Suppl): 34-40. 10.1016/j.urology.2006.08.1109.
Article
PubMed
Google Scholar
Enestrom S, Bengtsson A, Frodin T: Dermal IgG deposits and increase of mast cells in patients with fibromyalgia - relevant findings or epiphenomena?. Scand J Rheumatol. 1997, 26: 308-313. 10.3109/03009749709105321.
Article
CAS
PubMed
Google Scholar
Lucas HJ, Brauch CM, Settas L, Theoharides TC: Fibromyalgia - new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol. 2006, 19: 5-9.
CAS
PubMed
Google Scholar
Kolck UW: Investigations on the pathogenesis of the systemic mast cell activation syndrome and its impact on heart function. Bonn, University, medical thesis. 2009, URN:nbn:de:hbz:5N-19064, [http://hss.ulb.uni-bonn.de/2009/1906/1906.htm]
Google Scholar
Nickel JC, Tripp DA, Pontari MA, Moldwin RM, Mayer R, Carr LK, Doggweiler R, Yang CC, Whitcomb D, Mishra N, Nordling J: Phenotypic associations between interstitial cystitis/painfil bladder syndrome and irritable bowel syndrtome, fibromyalgia, chronis fatigue syndrome: a case control study. J Urology. 2009, 181 (Suppl): 19-10.1016/S0022-5347(09)60067-7.
Article
Google Scholar
Frieling T, Meis K, Kolck UW, Homann J, Hülsdonk A, Haars U, Hertfelder H-J, Oldenburg J, Seidel H, Molderings GJ: Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome. Z Gastroenterol. 2011, 49: 191-194. 10.1055/s-0029-1245707.
Article
CAS
PubMed
Google Scholar
Orfao A, Garcia-Montero AC, Sanchez L, Escribano L: REMA: Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol. 2007, 138: 12-30. 10.1111/j.1365-2141.2007.06619.x.
Article
CAS
PubMed
Google Scholar
Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, Hadj-Rabia S, Nasca L, Georgin-Lavialle S, Cohen-Akenine A, Launay JM, Barete S, Feger F, Arock M, Catteau B, Sans B, Stalder JF, Skowron F, Thomas L, Lorette G, Plantin P, Bordigoni P, Lortholary O, de Prost Y, Moussy A, Sobol H, Dubreuil P: Pediatric mastocytosis is a clonal disease associated with D(816)V and other activating c-KIT mutations. J Invest Dermatol. 2010, 130: 804-815. 10.1038/jid.2009.281.
Article
CAS
PubMed
Google Scholar
Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A, Aldanondo I, Sanchez L, Dominguez M, Botana LM, Sanchez-Jimenez F, Sotlar K, Almeida J, Escribano L, Orfao A: KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood. 2006, 108: 2366-2372. 10.1182/blood-2006-04-015545.
Article
CAS
PubMed
Google Scholar
Lawley W, Hird H, Mallinder P, McKenna S, Hargadon B, Murray A, Bradding P: Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis. Mutation Res. 2005, 572: 1-13. 10.1016/j.mrfmmm.2004.08.015.
Article
CAS
PubMed
Google Scholar
Mayerhofer M, Gleixner KV, Hoelbl A, Florian S, Hoermann G, Aichberger KJ, Bilban M, Esterbauer H, Krauth MT, Sperr WR, Longley JB, Kralovics R, Moriggl R, Zappulla J, Liblau RS, Schwarzinger I, Sexl V, Sillaber C, Valent P: Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J Immunol. 2008, 180: 5466-5476.
Article
PubMed Central
CAS
PubMed
Google Scholar
Teodosio C, García-Montero AC, Jara-Acevedo M, Sánchez-Muñoz L, Alvarez-Twose I, Núñez R, Schwartz LB, Walls AF, Escribano L, Orfao A: Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunopheno-types. J Allergy Clin Immunol. 2010, 125: 719-726. 10.1016/j.jaci.2009.10.020.
Article
CAS
PubMed
Google Scholar
Yang Y, Létard S, Borge L: Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood. 2010, 116: 1114-1123. 10.1182/blood-2009-06-226027.
Article
CAS
PubMed
Google Scholar
Gotlib J, Berubé C, Growney JD, Chen CC, George TI, Williams C, Kajiguchi T, Ruan J, Lilleberg SL, Durocher JA, Lichy JH, Wang Y, Cohen PS, Arber DA, Heinrich MC, Neckers L, Galli SJ, Gilliland DG, Coutré SE: Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood. 2005, 106: 2865-2870. 10.1182/blood-2005-04-1568.
Article
PubMed Central
CAS
PubMed
Google Scholar
Molderings GJ, Kolck U, Scheurlen C, Brüss M, Frieling T, Raithel M, Homann J: Systemic mast cell disease with gastrointestinal symptoms - a diagnostic questionnaire. Dtsch Med Wochenschr. 2006, 131: 2095-2100. 10.1055/s-2006-951337.
Article
CAS
PubMed
Google Scholar
Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D: Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007, 217: 65-78. 10.1111/j.1600-065X.2007.00519.x.
Article
CAS
PubMed
Google Scholar
Roberts LJ, Oates JA: Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol. 1991, 96 (3 Suppl): 19S-24S. 10.1111/1523-1747.ep12468945.
Article
Google Scholar
Butterfield JH, Li C-Y: Bone marrow biopsies for the diagnosis of systemic mastocytosis: is one biopsy sufficient?. Am J Clin Path. 2004, 121: 264-267. 10.1309/2EWQKN00PG02JKY0.
Article
PubMed
Google Scholar
Molderings GJ, Raithel M, Kratz F, Azemar M, Haenisch B, Harzer S, Homann J: Omalizumab treatment of systemic mast cell activation disease: experiences from four cases. Intern Med. 2011, 50: 1-5. 10.2169/internalmedicine.50.4640.
Article
Google Scholar
Droogendijk HJ, Kluin-Nelemans HJC, van Doormaal JJ, Oranje AR, van de Loosdrecht AA, van Daele PLA: Imatinib mesylate in the treatment of systemic mastocytosis - A phase II trial. Cancer. 2006, 107: 345-351. 10.1002/cncr.21996.
Article
CAS
PubMed
Google Scholar
Gotlib J, George TI, Corless C, Linder A, Ruddell A, Akin C, DeAngelo DJ, Kepten I, Lanza C, Heinemann H, Yin O, Gallagher N, Graubert T: The Kit tyrosine kinase inhibitor midostaurine (PKC412) exhibits a high response rate in aggressive systemic mastocytosis (ASM): interim results of a phase II trial. Blood. 2008, 110: 1039A-
Google Scholar
Verstovsek S, Tefferi A, Cortes J, O'Brien S, Garcia-Manero G, Pardanani A, Akin C, Faderl S, Manshouri T, Thomas D, Kantarjian H: Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res. 2008, 14: 3906-3915. 10.1158/1078-0432.CCR-08-0366.
Article
CAS
PubMed
Google Scholar
Vega-Ruiz A, Cortes JE, Sever M, Manshouri T, Quintás-Cardama A, Luthra R, Kantarjian HM, Verstovsek S: Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis. Leuk Res. 2009, 33: 1481-1484. 10.1016/j.leukres.2008.12.020.
Article
PubMed Central
CAS
PubMed
Google Scholar
Parikh SA, Kantarjian HM, Richie MA, Cortes JE, Verstovsek S: Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis. Leuk Lymph. 2010, 51: 269-274. 10.3109/10428190903486220.
Article
CAS
Google Scholar
de Olano DG, Twose IA, Esteban López MI, Muñoz LS, Alonso Díaz de Durana MD, Castro AV, Montero AG, González-Mancebo E, González TB, Herrero Gil MD, Fernández-Rivas M, Orfao A, de la Hoz Caballer B, Castells MC, Mora LE: Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol. 2008, 121: 519-526. 10.1016/j.jaci.2007.11.010.
Article
Google Scholar
Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, Birnbaum J, Bodzenta-Lukaszyk A, Bonifazi F, Bucher C, Campi P, Darsow U, Egger C, Haeberli G, Hawranek T, Körner M, Kucharewicz I, Küchenhoff H, Lang R, Quercia O, Reider N, Severino M, Sticherling M, Sturm GJ, Wüthrich B: Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009, 124: 1047-1054.
Article
PubMed
Google Scholar
Bonadonna P, Zanotti R, Müller U: Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010, 10: 347-353. 10.1097/ACI.0b013e32833b280c.
Article
CAS
PubMed
Google Scholar
Valent P, Sperr WR, Akin C: How I treat patients with advanced systemic mastocytosis. Blood. 2010, 116: 5812-5817. 10.1182/blood-2010-08-292144.
Article
CAS
PubMed
Google Scholar
Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A: Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009, 113: 5727-5736. 10.1182/blood-2009-02-205237.
Article
CAS
PubMed
Google Scholar
Simon J, Lortholary O, Caillat-Vigneron N, Raphael M, Martin A, Briere J, Barete S, Hermine O, Casussus P: Interest of interferon alpha in systemic mastocytosis. The french experience and review of the literature. Pathol Biol. 2004, 52: 294-299. 10.1016/j.patbio.2004.04.012.
Article
CAS
PubMed
Google Scholar
Butterfield JH: Interferon treatment for hypereosinophilic syndromes ans systemic mastocytosis. Acta haematol. 2005, 114: 26-40. 10.1159/000085560.
Article
CAS
PubMed
Google Scholar
Afrin LB: Polycythemia from mast cell activation disorder: lessons from incongruence of symptoms vs. test results. Am J Med Sci. 2011,
Google Scholar
Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, Palmerini F, Dubreuil P, Arock M, Roux C, Launay JM, Fraitag S, Canioni D, Billemont B, Suarez F, Lanternier F, Lortholary O, Hermine O, Francès C: Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis. 2010, 69: 1838-1841. 10.1136/ard.2009.124511.
Article
CAS
PubMed
Google Scholar
Molderings GJ, Solleder G, Kolck UW, Homann J, Schröder D, von Kügelgen I, Vorreuther R: Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics. Urol Res. 2009, 37: 227-229. 10.1007/s00240-009-0198-0.
Article
PubMed
Google Scholar